iShares Genomics Immunology and Healthcare ETF

The iShares Genomics Immunology and Healthcare ETF is a thematic exchange-traded fund that targets companies at the forefront of genomic science, immunology, and healthcare innovation. Its primary function is to provide investors with exposure to global equities driving advancements in areas such as genetic research, biotechnology, bioengineering, and pharmaceutical development. The ETF tracks the NYSE FactSet Global Genomics and Immuno Biopharma Index using a market-cap-weighted methodology, ensuring broad coverage of industry leaders and innovators in developed and emerging markets. Core holdings typically include prominent biotechnology firms, pharmaceutical manufacturers, and life sciences companies that are pioneering diagnostic tools, the development of new therapies, and next-generation healthcare solutions. It encompasses sectors including healthcare equipment and services, as well as cutting-edge drug research, particularly those involved in breakthrough technologies like gene editing and immunotherapy. Launched in June 2019, the fund offers both growth and value exposure to a rapidly evolving segment of the healthcare market. It serves as a strategic vehicle for capturing the potential of medical discoveries that can reshape patient care, disease prevention, and treatment paradigms worldwide, highlighting its significance within the global investment landscape.